Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 6

The role of specialized prevention clinics for the short term follow-up of acute coronary syndromes

Akut koroner sendrom sonrası erken dönem izlemde özelleşmiş korunma polikliniklerinin rolü

Pages
498–505
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the recommended treatments were similar in both groups, the statin use rate was significantly higher in Group 1 (95.5% vs. 80.3%, p=0.021) at 6 months.Conclusion: The results of the study showed that specialized prevention clinics were more effective during the management of cardiovascular risk factors after ACS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to investigate the effect of specialized prevention clinics and standard clinics follow-ups on secondary protection after acute coronary syndrome (ACS) on cardiovascular risk factors.Methods: A total of 118 patients who received thrombolytic therapy after being diagnosed with ST-segment elevation myocardial infarction were followed up for 6 months.
📊
Key Findings & Data:After ACS, patients in a specialized prevention clinic (Group 1) (n=67) and those in a standard clinic (Group 2) (n=51) were compared in terms of the change in their lifestyle, management of risk factors, and drug compliance.Results: No significant difference was found between groups in terms of baseline clinical and laboratory findings except for triglyceride level (Group 1: median 174 mg/dL; Group 2: median 136 mg/dL; p=0.039).
💡
Conclusion & Impact:Although the recommended treatments were similar in both groups, the statin use rate was significantly higher in Group 1 (95.5% vs. 80.3%, p=0.021) at 6 months.Conclusion: The results of the study showed that specialized prevention clinics were more effective during the management of cardiovascular risk factors after ACS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aimed to investigate the effect of specialized prevention clinics and standard clinics follow-ups on secondary protection after acute coronary syndrome (ACS) on cardiovascular risk factors.Methods: A total of 118 patients who received thrombolytic therapy after being diagnosed with ST-segment elevation myocardial infarction were followed up for 6 months. After ACS, patients in a specialized prevention clinic (Group 1) (n=67) and those in a standard clinic (Group 2) (n=51) were compared in terms of the change in their lifestyle, management of risk factors, and drug compliance.Results: No significant difference was found between groups in terms of baseline clinical and laboratory findings except for triglyceride level (Group 1: median 174 mg/dL; Group 2: median 136 mg/dL; p=0.039). Six months after indexing, smoking cessation (72.4% vs. 50%, p=0.037), diet compliance (43% vs.19.6%, p=0.012), and exercise rates (31% vs. 13.7%, p=0.044) were significantly higher in Group 1. Although the weight control rate was higher in Group 1, no significant difference was noted between the groups (27% vs. 15.6%, p=0.219). The rate of systolic and diastolic blood pressures >140/90 mm Hg was significantly higher in Group 2 (23.5% vs. 9%, p=0.029) at 6 months. The median low-density lipoprotein cholesterol (LDL-C) value was significantly lower in Group 1 patients (Group 1: 91 mg/dL; Group 2: 102 mg/dL; p=0.042). Moreover, the rate of LDL-C =50% reduction compared with baseline was significantly higher in Group 1 (32.8% vs. 13.7%, p=0.016). Although the recommended treatments were similar in both groups, the statin use rate was significantly higher in Group 1 (95.5% vs. 80.3%, p=0.021) at 6 months.Conclusion: The results of the study showed that specialized prevention clinics were more effective during the management of cardiovascular risk factors after ACS.

Özet

Amaç: Akut koroner sendrom (AKS) sonrasında ikincil korumada yapılandırılmış poliklinik ile standart poliklinik takibinin kardiyovasküler risk faktörlerinin kontrolündeki etkisinin araştırılması.Yöntemler: ST-segment yükselmeli miyokart enfarktüsü tanısıyla trombolitik tedavi alan 118 hasta altı ay takip edildi. Akut koroner sendrom sonrasında yapılandırılmış poliklinikte (Grup 1) takipli hastalar (n=67) ile standart poliklinikte (Grup 2) takipli hastalar (n=51); yaşam şekli değişikliği, risk faktörlerinin yönetimi ve ilaç uyumu açısından karşılaştırıldı.Bulgular: Gruplar arasında trigliserit düzeyi dışında (Grup 1 medyan 174 mg/dL, Grup 2 medyan 136 mg/dL; p=0.039) bazal klinik ve laboratuvar özellikleri açısından fark saptanmadı. İndeks olaydan altı ay sonra Grup 1'de sigara bırakma (%72.4'e karşın %50; p=0.037), önerilen diyete uyma (%43'e karşın %19.6; p=0.012) ve egzersiz yapma oranları (%31'e karşın %13.7; p=0.044) anlamlı olarak daha yüksek idi. Kilo kontrol oranı Grup 1'de daha yüksek olmasına rağmen gruplar arasında anlamlı fark saptanmadı (%27'ye karşın %15.6; p=0.219). Altıncı ayda sistolik ve diyastolik kan basıncı >140/90 mmHg olanların oranı Grup 2' de anlamlı olarak daha yüksek saptandı (%23.5'e karşın %9; p=0.029). Grup 1 hastalarında medyan LDL-K değeri belirgin olarak düşük saptandı (Grup 1, 91 mg/dL, Grup 2, 102 mg/dL; p=0.042). Ayrıca LDL-K =%50 azalma olanların oranı Grup 1'de belirgin yüksek idi (%32.8'e karşın %13.7; p=0.016). Altıncı ay kontrolde önerilen tedaviler açısından fark yok iken Grup 1'de statin kullanım oranı belirgin yüksek idi (%95.5'e karşın %80.3; p=0.021).Sonuç: Çalışmamızın sonuçları yapılandırılmış polikliniklerin AKS sonrasında kardiyovasküler risk faktörlerinin yönetiminde daha etkin olduğu göstermektedir.

🔖

Cite This Article

KAYIKÇIOĞLU, M., ŞİMŞEK, E., TÜRKOĞLU, C., YÜCE, E. İ., KEMAL, H. S., KILIÇ, S. (2022). The role of specialized prevention clinics for the short term follow-up of acute coronary syndromes. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 6, 498–505. https://ajindex.com/articles/632235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Løgstrup S, O'Kelly S. European Cardiovascular Disease Statistics 2012 edition. European Heart Network and European Society of Cardiology, September 2012. Available at: https:// www.escardio.org/static_file/Escardio/Press-media/pressreleases/2013/EU-cardiovascular-disease-statistics-2012.pdf. Accessed May 31, 2017
  2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362:2155-65
  3. Terkelsen CJ, Lassen JF, Nørgaard BL, Gerdes JC, Jensen T, Gøtzsche LB, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005;26:18- 26
  4. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al; Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-93
  5. Onat A, Yüksel M, Köroğlu B, Gümrükçüoğlu HA, Aydın M, Cakmak HA, et al. Turkish Adult Risk Factor Study survey 2012: overall and coronary mortality and trends in the prevalence of metabolic syndrome. Turk Kardiyol Dern Ars 2013;41:373-8
  6. Özkan AA. Acute coronary syndromes: epidemiology. Turk Kardiyol Dern Ars 2013;41 Suppl 1:1-3
  7. Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA; GRACE and GRACE2 Investigators. The Global Registry of Acute Coronary Events, 1999 to 2009-GRACE. Heart 2010;96:1095-101
  8. Peterson ED, Roe MT, Mulgund J, DeLong ER, Lytle BL, Brindis RG, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20
  9. Tokgözoğlu L, Kaya EB, Erol C, Ergene O; EUROASPIRE III Turkey Study Group. EUROASPIRE III: a comparison between Turkey and Europe. Turk Kardiyol Dern Ars 2010;38:164-72
  10. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44
  11. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298- 304
  12. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized contr